PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Movement Disorders10.14802/jmd.16045201710135-39Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced ParkinsonismSeung Ha Lee, Han Kyeol Kim, Young Gun Lee, Chul Hyoung Lyoo, Sung Jun Ahn, Myung Sik Leehttp://e-jmd.org/journal/view.php?doi=10.14802/jmd.16045, http://e-jmd.org/upload/jmd-16045.pdf, http://www.e-jmd.org/upload/jmd-16045.pdf
Neurotoxicology and Teratology10.1016/j.ntt.2015.04.152201549148Manganese-induced parkinsonism does not involve degeneration of nigrostriatal dopaminergic neurons: Evidence from genetic mutations and environmental exposure in humans and non-human primatesTomás R. Guilartehttps://api.elsevier.com/content/article/PII:S0892036215001890?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0892036215001890?httpAccept=text/xml
Parkinsonism & Related Disorders10.1016/s1353-8020(09)70651-0200915S170-S171P3.087 Carbon monoxide poisoning induced nigrostriatal dopaminergic dysfunction detected using Positron Emission Tomography (PET)E. Rissanen, T. Paavilainen, J. Virta, L. Airas, R.J. Marttila, J. Rinnehttps://api.elsevier.com/content/article/PII:S1353802009706510?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1353802009706510?httpAccept=text/plain
Parkinsonism & Related Disorders10.1016/j.parkreldis.2015.10.477201622e187Apocyanin, a microglial NADPH oxidase inhibitor prevents dopaminergic neuronal degeneration in lipopolysaccharide induced Parkinson's disease modelNeha Sharma, Bimla Nehruhttps://api.elsevier.com/content/article/PII:S135380201500913X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S135380201500913X?httpAccept=text/plain
Parkinsonism & Related Disorders10.1016/s1353-8020(09)70473-0200915S122P2.122 PPAR-gamma agonist rosiglitazone stops the progressive dopaminergic degeneration induced by chronic MPTP in miceA. Carta, L. Frauhttps://api.elsevier.com/content/article/PII:S1353802009704730?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1353802009704730?httpAccept=text/plain
European Journal of Neurology10.1111/j.1468-1331.2009.02854.x2009173487-492The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorderY. K. Kim, I-Y. Yoon, J-M. Kim, S-H. Jeong, K. W. Kim, Y-K. Shin, B. S. Kim, S. E. Kimhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1468-1331.2009.02854.x
Neurology International10.4081/ni.2018.78772018104Clinical features of drug-induced ParkinsonismNobuko Shiraiwa, Akira Tamaoka, Norio Ohkoshihttps://www.pagepress.org/journals/index.php/ni/article/download/7877/7677, https://www.pagepress.org/journals/index.php/ni/article/download/7877/7677
Parkinsonism & Related Disorders10.1016/j.parkreldis.2015.10.273201622e117Gastrointestinal symptom is a significant indicator of nigrostriatal dopaminergic degeneration in idiopathic REM sleep behavior disorder patientsJee-Young Lee, Cheol Min Shin, Eun Jin Yun, Yu-Kyeong Kim, Beom Seok Jeonhttps://api.elsevier.com/content/article/PII:S1353802015007099?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1353802015007099?httpAccept=text/plain
Parkinsonism & Related Disorders10.1016/s1353-8020(11)70281-4201218S521.223 THE INFLUENCE OF DRUG CLASS ON THE MOTOR FEATURES OF DRUG-INDUCED PARKINSONISMR.P. Munhoz, M. Farah, C.S. Ikuta, H.A.G. Teivehttps://api.elsevier.com/content/article/PII:S1353802011702814?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1353802011702814?httpAccept=text/plain
Brain Research10.1016/0006-8993(76)90877-519761022201-215Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine systemFrance Javoy, Constantino Sotelo, Alain Herbet, Yves Agidhttps://api.elsevier.com/content/article/PII:0006899376908775?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0006899376908775?httpAccept=text/plain